Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.2428
-0.0034 (-1.38%)
At close: Sep 4, 2026, 4:00 PM EDT
0.2500
+0.0072 (2.97%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Vistagen Therapeutics Market Cap
Vistagen Therapeutics has a market cap or net worth of $10.77 million as of September 4, 2026. Its market cap has decreased by -90.48% in one year.
Market Cap
10.77M
Enterprise Value
-20.17M
1-Year Change
-90.48%
Ranking
Category
Stock Price
$0.24
ChartMarket Cap Chart
Since May 11, 2016, Vistagen Therapeutics's market cap has increased from $9.30M to $10.77M, an increase of 15.86%. That is a compound annual growth rate of 1.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 10.77M | -58.72% |
| Dec 31, 2025 | 26.10M | -68.21% |
| Dec 31, 2024 | 82.10M | -40.89% |
| Dec 29, 2023 | 138.90M | 552.11% |
| Dec 30, 2022 | 21.30M | -94.53% |
| Dec 31, 2021 | 389.40M | 171.17% |
| Dec 31, 2020 | 143.60M | 381.88% |
| Dec 31, 2019 | 29.80M | -36.05% |
| Dec 31, 2018 | 46.60M | 258.46% |
| Dec 29, 2017 | 13.00M | -58.47% |
| Dec 30, 2016 | 31.30M | 236.56% |
| May 11, 2016 | 9.30M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 11.61M |
| MetaVia | 11.53M |
| Kiora Pharmaceuticals | 11.28M |
| Daré Bioscience | 11.02M |
| Xenetic Biosciences | 10.94M |
| Azitra | 10.88M |
| GT Biopharma | 10.87M |
| Lunai Bioworks | 10.84M |